U2CCA233285
Cooperative Agreement
Overview
Grant Description
Center for pediatric tumor cell atlas
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Pennsylvania
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/23 to 08/31/25 and the total obligations have increased 414% from $2,560,774 to $13,154,378.
The Children's Hospital Of Philadelphia was awarded
Center for pediatric tumor cell atlas
Cooperative Agreement U2CCA233285
worth $13,154,378
from National Cancer Institute in September 2018 with work to be completed primarily in Pennsylvania United States.
The grant
has a duration of 7 years and
was awarded through assistance program 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot.
The Cooperative Agreement was awarded through grant opportunity Human Tumor Atlases (HTA) Research Centers (U2C).
Status
(Complete)
Last Modified 9/20/24
Period of Performance
9/30/18
Start Date
8/31/25
End Date
Funding Split
$13.2M
Federal Obligation
$0.0
Non-Federal Obligation
$13.2M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U2CCA233285
Transaction History
Modifications to U2CCA233285
Additional Detail
Award ID FAIN
U2CCA233285
SAI Number
U2CCA233285-1559455826
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
G7MQPLSUX1L4
Awardee CAGE
0GXU0
Performance District
PA-90
Senators
Robert Casey
John Fetterman
John Fetterman
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $15,670,442 | 100% |
Modified: 9/20/24